Dow Up1.33% Nasdaq Up1.33%

ResMed Inc. (RMD)

-NYSE
63.23 Up 1.20(1.93%) Jun 30, 4:06PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.8
Mean Recommendation (last week):2.7
Change:0.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:58.68
Median Target:57.00
High Target:74.30
Low Target:44.00
No. of Brokers:11

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 27, 2016NeedhamDowngradeHoldUnderperform
Apr 28, 2016MacquarieUpgradeUnderperformNeutral
Apr 27, 2016Piper JaffrayDowngradeOverweightNeutral
Jan 22, 2016Credit SuisseUpgradeNeutralOutperform
Jan 19, 2016BarclaysDowngradeEqual WeightUnderweight
Dec 17, 2015NeedhamDowngradeBuyHold
Jul 13, 2015MacquarieDowngradeNeutralUnderperform
Jun 25, 2015BarclaysInitiated Equal Weight
May 13, 2015BofA/MerrillDowngradeBuyNeutral
Apr 27, 2015GoldmanDowngradeBuyNeutral

More Upgrades & Downgrades for RMD

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111
Buy4455
Hold8877
Underperform2332
Sell0000

Data provided by Thomson/First Call


Currency in USD.